ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
NeoCitran Hustenstiller, Depottabletten - 10 Tablette(n)
48748016 Haleon Schweiz AG
NeoCitran Hustenstiller, Depottabletten28.12.1987
  28.12.1987
Butamirate (R05DB13)15.12.2004
WHO-DDD 
03.01.20.10 Tablette(n)
03.01.20. 
D  
No 
IPCI
PR  
k.A.PR
  
7680487480163Synthetika
  
Composition
butamirati dihydrogenocitras 50 mg, lactosum monohydricum 88 mg, acidum tartaricum, povidonum K 30, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis anhydrica, magnesii stearas, ricini oleum hydrogenatum, acidi ethacrylici et methylis methacrylatis polymerisatum, Überzug: polysorbatum 80, talcum, lactosum monohydricum 4.987 mg, acidi ethacrylici et methylis methacrylatis polymerisatum, E 127, E 171, E 172 (rubrum) pro compresso obducto.
Packungsbestandteile
Depottabletten
 
Active AgentDose
Butamirate Dihydrogen Citrate50 mg
 
Inactive agentsDoseadditional_information
(Rubrum) pro Compresso Obducto  
Acidi Ethacrylici  
Acidi Methacrylici  
Tartaric Acid  
E 127 color.
E 171 color.
E 172 color.
Ethylis Acrylatis Polymerisatum  
Hypromellosum  
Lactose Monohydrate4.987 mg 
Magnesii Stearas  
Methylis Methacrylatis Polymerisatum  
Polysorbatum 80 Überzug
Povidonum K30  
Ricini Oleum Hydrogenatum  
Silica Colloidalis Anhydrica  
Talcum  
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home